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The predominant interest and therapeutic elTort has been directed at the thrombolic
complications of polycythemia vera. This is proper inasmuch as throbosis is the chief
:cc of disability in the disease. This lendcncy to thrombosis is readily explained by
the increased blood viscosity, the high platelet count and the slowed rale of blood flow.
.Another major source of disability and occasional cause of death is the co-exislent
tendency to excessive bleeding. This is not often spontaneous bleeding, and attempts
to demonstrate a consistent defect in heniosl;isis have yieldetl equivoe:il results. This
would lead the casual observer to doubt that any real hazard of bleeding exists.
Nevertheless, this is a very real complication in terms of incidence and morbilitv.
Bleeding may be particularly troublesome because:
a) It is often unexpected in the absence of relevant familv ;ind past histor\'.
b) It may occur only after surgery or trauma, and
c) Blood loss may be so severe that it masks the umlerKing disease.
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Figure 1
Site of bleeding in polycythemia.

A review of several larije series indicates an incidence of hemorrhagic complications
as high as 30%'*. While this is often limited to post-traumatic hemorrhage,
•spontaneous bleeding does occur. The site of bleeding is variable as indicated in fig. I .
Purpuric and ecchymotic lesions may be quite extensive* as shown in fig. 2.
'Presented in part at the Eighlh Annual Michigan Regional Meeting ol the American College of
sicians.
•Division of Hematology.
•Division of Coagulation. Presenl address: Dept. of Medicine, Marquette University School of
Medicine. Milwaukee. Wisconsin.
^Division of Coagulalion. Present address: Dept. of Physiological Pharmacology, College of Medi
^>-inc. Wayne Slate University, Detroit, Michigan.
'Drvision of Coagulalion.
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Figure 2
I vii Msoe hematoma of the arm — an initial symptom in this patient.

MATERIALS A N D METHODS
IhiriN |i.iiienls with pol\c\lhemi;i vera who have been treated regularly at the
11. Ill \ Eoril Hospital were stiulied. This was a represenKitive szroup, including palienh
with treated, iniire.iud ;ind spent polyc\ih.'mia. Their records were reviewed in order
lo determine the n.iture of hemorihage in this disorder — its incidence, severity and
duration, .is well .is ihe precipil:iting factors. After clinical evaluation, these patienb
h.iil ,1 heniosi.iiie siii\e\ which included convention;il bleeding time, coagulation time.
tourim|iiei test, pioihronibin lime, prothrombin consumption, fibrinogen determiiu'tion.
irul pi,ism.1 eloiiinL' lime In .idililion, isolated platelets of these patients were assayed
lor l.ieioi « .leiivilv. Also, detailed and qu;inlilalive observalions were made of the
.ilinoim.ll behiiNKM of the poKcMhemic clot.
.Abnorm.ilities in the rale of clot retraction,' the electrolytic resistance of the
reir.iciing clot.' .ind the retention of red cells by the clot' have been previously noted
In vitro, the clot is i\pie.ill\ of small volume, and most of the red cells are lost from
ihc clot, i.illing to Ihe bottom of Ihe test tube (fig. 3) We have devised a quantitative
me.isiirc ol Ihe loss of red cells from the reliacting clot — the '•fall-out" phenomenon. In
essence this iruohes .i qu.intilalive dclerminalion of the hemoglobin lost by the cIoI
Irom .1 me.isuieil volume ot bloi>d. The latter may then be expressed as a per cent of
the whole IMood hemoglobin In toriv normal controls this value was in the range
ol 20-40'^;.
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RESULTS A N D COMMENTS
Ciinically significant bleeding occurred at some time during their course in 3(i'<
these palients. The sites of bleeding are indicated in fig. 1. Whole conventional
studies of the hemostilic mechanism in polycythemia vera returned normal values, this
-ludy revealed consistent deficiencies in platelet factor 3 activity and in the platcleltihrin network of the clot. The former was reflected in the faclor 3 assay of polycylheni'C platelets (fig. 4) and in the thromboplastin generation test. The latier was reflected
in the excessive fall-out value of polycythemic clots. The loss of red cells from Ihe clot
. sisiently exceeded 45 ""r, and was often in the ranue of fiO-95'i .

Figure 3
The "fall-out" phenomenon. The polvcvthemic clol fright) has lost much of the red cell mass,
Conlrol is on the left.

This excessive fall-out was apparent in patienls with polycythemia vera who had
Tianitest thrombocytosis at some time during their course. It was reduced b\ tre;ilmeni.
''Ut Was not abolished even when hematocrit and hemoglobin values were reduced to
•-ubnormal values. Thrombocytoses due to other cause, and moderate elevations ol
hemoglobin due to other forms of erylhrocytosis were not reflecled in excessive fall-out.
''Uggesiing that the test may have some diagnostic screening value in relation to poK'^.vthemia vera. However, very marked elevations of hemoglobin (in excess of 20 gms.)
'"secondary polycythemia were associaled with excessive loss ol red cells from the clot.
The test is of greatest value prior to treatment in that the fall-out is oflen ieduce>l
•emporarily by venesection or radioaciive phosphorus treatment.
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Figure 4
Pljtclel factor } assay. This acliviiy of normal plalclels is shown in contrast to Ihe subnormal
.Kliwty of p.uieiu s (poluylhemic) pl.itelcts,
Ihe previously noted defects are probably not the only factors contributing to
exeessive bleeding in poKcyihemia \era, a) Physical distention of the vascular system
IS a pl.iusible e.iuse ol bleeding b) Some observers have presented evidence that intrav.isciil.ir ei>.iuulation depletes prothrombin and fibrinogen to a point where bleedini:
iKCurs.* c) The anticoagulant elTect of excessive numbers of platelets has been confirmed by Spaet. Bauer .ind .Melamed." d) On rare occasion, fibrinolytic activity
has been noted in polycylhemia vera." e) Preliminary results with the partial ihromK'pl.isiin test" in some ol our patienls have returned prolonged values, suggesting thai
Ihc plasma ol pc<Kc\lhemic patients may be less responsive to thromboplastin than
IS n< rmal plasma.
.Among the practical conclusions are the lollowing: 1) Polycythemia should be
suspected in bleeding patients whose convenlional studies appear to be normal
2) Tre.itment is ol v.due in presenlmg hemorrhage as well as thrombosis. It is true
lhal both complications iKCur in treated or controlled patients, but the incidence »
14
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considerably reduced by treatment. 3) Caution in the use of ;intico;igul.ints in these
patients is of vital importance. 4) Elective surgery in the untreated patient should
He deferred until control has been established with radioactive phosphorus. Emergency
surgerv should be preceded, if feasible, by reduction ol blood counts to normal i.in|'e
bv phlebotomy.
SUMMARY
The incidence and nature of hemorrhage in pol\c\lhemia vera has been reviewed,
A functional defect in the polycythemic pkilelel has been demonslrateil, and the
aberrant behavior of the clot has been confirmed. The latter has been studied in
derail and quanlitalivelv determined. The clinical application of some of these findings
11 ihe m.in.igement of patients with this disorder h;is been briefly outlrrn ,1
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